Femcon Side Effects
View Community-reported Femcon side effects
Add Your Side Effect to the Community Database
Help Community - Describe Your Femcon Side Effect
Have You dealt with a Femcon side effect? Share your experience
Femcon Side Effects summary
Total Femcon reports: 30.Femcon FDA safety alerts: No.
Reported deaths: 5 Reported hospitalizations: 8.
Take Femcon Side Effects Survey, Discuss Femcon with others
Femcon Side Effects: pulmonary embolism, dyspnoea, ovarian cyst, endometrial hypertrophy, blood follicle stimulating hormone increased, migraine, syncope, chest pain, deep vein thrombosis, thrombosis, post procedural haemorrhage,
More About Femcon.
If you have questions about Femcon, you can ask a Health Expert or Ask Patient Community about Femcon.
Femcon Side Effects reported to FDA
Femcon Side Effects Report #5651843-8
Physician from UNITED STATES reported FEMCON problem on Feb 20, 2008. Female patient was treated with FEMCON. FEMCON dosage: 0.4MG/35MCG, TRANSPLACENTAL. Patient died on 01/16/2008.
Femcon Side Effects Report #5654446-4
FEMCON problem was reported by a Physician from UNITED STATES on Feb 21, 2008. Female patient was diagnosed with contraception and was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: abortion induced, pregnancy. FEMCON dosage: 0.4MG/35 MCG; QD, ORAL, 0.4 MG/35 MCG, 1D, TRANSPLACENTAL. During the same period patient was treated with FEMCON FE. Patient died.
Femcon Side Effects Report #5654458-0
Physician from UNITED STATES reported FEMCON problem on Feb 20, 2008. Female patient, 36 years of age, was diagnosed with contraception and was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: pregnancy on oral contraceptive. FEMCON dosage: 0.4MG/35MCG, QD, ORAL. Patient died on 01/16/2008.
Femcon Side Effects Report #5654459-2
FEMCON problem was reported by a Physician from UNITED STATES on Feb 21, 2008. Female patient, 37 years of age, weighting 147.9 lb, was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: abortion induced, pregnancy on oral contraceptive. FEMCON dosage: 0.4 MG/35MCG, QD, ORAL. During the same period patient was treated with EFFEXOR, FAMVIR, ALLEGRA. Patient recovered.
Femcon Side Effects Report #5621653-6
Consumer or non-health professional from UNITED STATES reported FEMCON problem on Jan 22, 2008. Female patient, 34 years of age, weighting 246.9 lb, was diagnosed with contraception, menorrhagia and was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: arachnoid cyst, benign intracranial hypertension, blood thyroid stimulating hormone abnormal, eyelid bleeding, headache, optic disc disorder, papilloedema, vision blurred. FEMCON dosage: unknown. During the same period patient was treated with FEMCON FE, LEVOXYL. Patient recovered.
Femcon Side Effects Report #5642325-8
FEMCON problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 07, 2008. Female patient, 34 years of age, weighting 250.0 lb, was diagnosed with contraception, menorrhagia and was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: arachnoid cyst, benign intracranial hypertension, blood thyroid stimulating hormone abnormal, haemorrhage, headache, optic disc disorder, papilloedema, vision blurred, visual acuity reduced. FEMCON dosage: unknown. During the same period patient was treated with FEMCON FE, LRVOXYL, DIAMOX. Patient recovered.
Femcon Side Effects Report #5619501-3
Consumer or non-health professional from UNITED STATES reported FEMCON problem on May 17, 2007. Female patient, 30 years of age, weighting 244.9 lb, was diagnosed with menstruation irregular, ovarian cyst and was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, pulmonary embolism. FEMCON dosage: 0.4 MG/35 MCG, QD, ORAL. During the same period patient was treated with FEMCON FE, OVCON, ADVAIR DISKUS. Patient was hospitalized. Patient recovered.
Femcon Side Effects Report #5619502-5
FEMCON problem was reported by a Consumer or non-health professional from UNITED STATES on June 08, 2007. Female patient, 24 years of age, weighting 229.9 lb, was diagnosed with contraception and was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: amenorrhoea, blood pressure increased, chest discomfort, dizziness, hypoaesthesia. FEMCON dosage: 0.4 MG/35 MCG, QD, ORAL. Patient recovered.
Femcon Side Effects Report #5619503-7
Consumer or non-health professional from UNITED STATES reported FEMCON problem on Aug 14, 2007. Female patient was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. FEMCON dosage: 0.4MG/35MCG. Patient recovered.
Femcon Side Effects Report #5619504-9
FEMCON problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 30, 2007. Female patient, 42 years of age, was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. FEMCON dosage: 0.4MG/35 MCG, QD, ORAL. Patient was hospitalized. Patient recovered.
Femcon Side Effects Report #5535026-8
Health Professional from UNITED STATES reported FEMCON problem on Nov 20, 2007. Female patient, 17 years of age, weighting 110.0 lb, was diagnosed with contraception and was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, haemorrhage, metrorrhagia, pregnancy. FEMCON dosage: 0.4MG/35MCG, QD, ORAL. During the same period patient was treated with LOESTRIN. Patient recovered.
Femcon Side Effects Report #5535027-X
FEMCON problem was reported by a Health Professional from UNITED STATES on Nov 20, 2007. Female patient was diagnosed with contraception and was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, blighted ovum. FEMCON dosage: 0.4MG/35MCG, QD, ORAL. Patient died.
Femcon Side Effects Report #5568048-1
Physician from UNITED STATES reported FEMCON problem on Dec 05, 2007. Female patient, 28 years of age, weighting 194.9 lb, was diagnosed with contraception and was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, pregnancy on oral contraceptive. FEMCON dosage: 0.4MG/35MCG, QD, ORAL. During the same period patient was treated with OVCON. Patient recovered.
Femcon Side Effects Report #5568328-X
FEMCON problem was reported by a Physician from UNITED STATES on Dec 05, 2007. Female patient was diagnosed with contraception and was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, pregnancy on oral contraceptive. FEMCON dosage: 0.4 MG/35MCG, QD, TRANSPLACENTAL. Patient died.
Femcon Side Effects Report #5574390-0
Consumer or non-health professional from UNITED STATES reported FEMCON problem on Dec 11, 2007. Female patient, 34 years of age, was diagnosed with contraception and was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: blood thyroid stimulating hormone abnormal, brain oedema, nerve injury, papilloedema. FEMCON dosage: unknown. Patient recovered.
Femcon Side Effects Report #5507214-8
FEMCON problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 19, 2007. Female patient, 40 years of age, weighting 168.9 lb, was diagnosed with contraception, ovarian cyst and was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: acne, amenorrhoea, ovarian cyst ruptured. FEMCON dosage: 0.4MG/35MCG, QD, ORAL. During the same period patient was treated with FEMCON FE, LOESTRIN. Patient recovered.
Femcon Side Effects Report #5533314-2
Consumer or non-health professional from UNITED STATES reported FEMCON problem on Nov 14, 2007. Female patient, 18 years of age, was diagnosed with haemorrhage and was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: anaemia, blood iron decreased, dyspnoea, hyperhidrosis, pain in extremity, vision blurred. FEMCON dosage: 0.4MG/35MCG, QD, ORAL, THREE TO FOUR TIME DAILY, ORAL. During the same period patient was treated with FEMCON FE, ZOLOFT, HALDOL, PAXIL, IRON, CODEINE SUL. Patient recovered.
Femcon Side Effects Report #5479073-3
FEMCON problem was reported by a Physician from UNITED STATES on Sept 17, 2007. Female patient, 18 years of age, was diagnosed with haemorrhage, vaginal haemorrhage and was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: anaemia, dyspnoea, hyperhidrosis, pain in extremity, vision blurred. FEMCON dosage: 0.4MG/35MCG, QD, ORAL THREE TO FOUR TIMES DAILY, ORAL. During the same period patient was treated with FEMCON FE, FEMCON FE, FEMCON FE, ZOLOFT, HALDOL, PAXIL, CODEINE SUL. Patient recovered.
Femcon Side Effects Report #5489186-8
Consumer or non-health professional from UNITED STATES reported FEMCON problem on Oct 01, 2007. Female patient was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, intentional overdose, intentional self-injury. FEMCON dosage: 0.4MG/35MCG, QD, ORAL. Patient recovered.
Femcon Side Effects Report #5447563-5
FEMCON problem was reported by a Health Professional from UNITED STATES on Sept 05, 2007. Female patient, 25 years of age, weighting 170.0 lb, was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: migraine, pulmonary embolism. FEMCON dosage: unknown. Patient was hospitalized. Patient recovered.
Femcon Side Effects Report #5452118-2
Physician from UNITED STATES reported FEMCON problem on Aug 28, 2007. Female patient was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: blood follicle stimulating hormone increased, endometrial hypertrophy, ovarian cyst. FEMCON dosage: 0.4MG/35 MCG, ORAL. Patient recovered.
Femcon Side Effects Report #5397667-0
FEMCON problem was reported by a Pharmacist from UNITED STATES on July 23, 2007. Female patient, 22 years of age, weighting 156.5 lb, was diagnosed with oral contraception and was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: chest pain, dyspnoea, syncope. FEMCON dosage: unknown. Patient was hospitalized. Patient recovered.
Femcon Side Effects Report #5397667-0
Pharmacist from UNITED STATES reported FEMCON problem on July 23, 2007. Female patient, 22 years of age, weighting 156.5 lb, was diagnosed with oral contraception and was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: chest pain, dyspnoea, syncope. FEMCON dosage: unknown. Patient was hospitalized. Patient recovered.
Femcon Side Effects Report #5777993-3
FEMCON problem was reported by a Consumer or non-health professional from UNITED STATES on June 02, 2008. Female patient, 24 years of age, weighting 190.0 lb, was diagnosed with contraception, hormone level abnormal and was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: gastritis, metrorrhagia. FEMCON dosage: 0.4MG/35MCG, QD, ORAL. During the same period patient was treated with FEMCON FE. Patient was hospitalized. Patient recovered.
Femcon Side Effects Report #5778773-5
Consumer or non-health professional from UNITED STATES reported FEMCON problem on June 09, 2008. Male patient was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: accidental exposure. FEMCON dosage: unknown. Patient recovered.
Femcon Side Effects Report #5376905-4
FEMCON problem was reported by a Consumer or non-health professional from UNITED STATES on June 28, 2007. Female patient, 30 years of age, weighting 254.0 lb, was diagnosed with ovarian cyst and was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, pulmonary embolism. FEMCON dosage: unknown. During the same period patient was treated with OVCON. Patient was hospitalized. Patient recovered.
Femcon Side Effects Report #5324248-7
Consumer or non-health professional from UNITED STATES reported FEMCON problem on Apr 24, 2007. Female patient, 29 years of age, weighting 170.0 lb, was diagnosed with contraception, menorrhagia and was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: abdominal hernia, abdominal pain, device failure, dyspnoea, haemoglobin decreased, oedema peripheral, post procedural haemorrhage, thrombosis. FEMCON dosage: unknown. During the same period patient was treated with FEMCON FE, SYNTHROID. Patient was hospitalized. Patient recovered.
Femcon Side Effects Report #5295678-7
FEMCON problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 10, 2007. Female patient, weighting 180.0 lb, was diagnosed with anaemia, vaginal haemorrhage and was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: dizziness, nausea. FEMCON dosage: unknown. During the same period patient was treated with FEMCON FE CHEWABLE. Patient recovered.
Femcon Side Effects Report #5306910-5
Physician from UNITED STATES reported FEMCON problem on Apr 05, 2007. Female patient was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock. FEMCON dosage: unknown. Patient recovered.
Femcon Side Effects Report #5336193-1
FEMCON problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 12, 2006. Female patient, 27 years of age, weighting 119.9 lb, was diagnosed with contraception and was treated with FEMCON. After drug was administered, patient experienced the following problems/side effects: pruritus, sleep disorder. FEMCON dosage: 0.4 MG/35MCG, SINGLE, ORAL. During the same period patient was treated with LOESTRIN, BACTRIM. Patient recovered.